- Home
- CLPT vs LAB Comparison
CLPT vs LAB Comparison
Compare CLPT & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLPT | LAB |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.6M | 488.4M |
| IPO Year | 2009 | 2008 |
Fundamental Metrics
Financial Performance| Metric | CLPT | LAB |
|---|---|---|
| Price | $11.03 | $0.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $21.50 | $1.35 |
| AVG Volume (30 Days) | 948.0K | ★ 2.4M |
| Earning Date | 04-06-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 22.22 | ★ 44.68 |
| EPS | N/A | ★ N/A |
| Revenue | $31,390,000.00 | ★ $101,937,000.00 |
| Revenue This Year | $18.93 | N/A |
| Revenue Next Year | $51.64 | $2.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 31.04 | N/A |
| 52 Week Low | $8.63 | $0.92 |
| 52 Week High | $30.10 | $1.72 |
Technical Indicators
Market Signals| Indicator | CLPT | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 43.66 | 27.51 |
| Support Level | $10.57 | N/A |
| Resistance Level | $11.69 | $1.41 |
| Average True Range (ATR) | 0.99 | 0.07 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 36.81 | 8.57 |
Price Performance
Historical ComparisonAbout CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.